- 2 accumulation markers appear in the recent smart-money tape.
- Latest weekly return ranks in the strongest part of its sector group.
AVTX
AMS
Week ended 07 Aug 2026
Weekly Investor Report
Avantium N.V. · Basic Materials · Specialty Chemicals
Latest close
7.06 EUR
7.6%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -2.2% below the Trend Line and sits at 13.8% of its 52-week range. The latest completed week returned 7.6%, after a -0.4% four-week move. The latest news-sentiment score is 41/100.
Setup score
23
out of 100
Latest Close
7.06 EUR
7 Aug 2026
1W Return
7.6%
latest completed week
4W Return
-0.4%
short-term follow-through
12W Return
-13.5%
quarterly tape
Trend Breadth
25.0%
13 of 52 weeks active
Volume Ratio
1.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
7.6%
Latest completed week; four-week move -0.4%.
Indicator stack
14/0
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 43.30%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
41/100
13 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -2.2% below the Trend Line and sits at 13.8% of its 52-week range. The latest completed week returned 7.6%, after a -0.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3712-week average 0.52
12-week confirmation
Trend active9/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.37Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
2 accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -0.4% over four weeks, -13.5% over 12 weeks, and -51.0% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year13
Trend breadth25.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.72Latest activity-pressure read.
Pressure change-507.4%Four-week change in activity pressure.
Leadership-15.98Latest relative-leadership reading.
RS change25.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment41/100
Weighted news tone is negative across 13 relevant articles.
1 positive · 7 neutral · 5 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-51.4%Distance below the 52-week high.
13-week volatility6.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2612 weeks finished lower.
Best week+14.8%Week of 17 Apr.
Worst week-11.6%Week of 12 Jun.
Latest week+7.6%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains10
Flat weeks0
Modest losses6
Sharp losses6
Recent vol6.3%13-week weekly-return volatility.
Base vol8.2%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew5.0% / -6.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorNL Basic Materials
4-week rank7 / 12
Group average3.9%
Trend breadth66.7%
Trend66.7%active weekly trend signals
MD41.7%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
IndustryNL Specialty Chemicals
4-week rank4 / 7
Group average5.3%
Trend breadth71.4%
Trend71.4%active weekly trend signals
MD57.1%positive activity pressure
RS42.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape20/100
Trend, activity pressure, participation, and risk combine to a 20/100 tape read.
Indicator analysis51/100Latest 12-week confirmation: trend 9/12, activity pressure 8/12, relative leadership 0/12.
Activity pressure 0.37; No reversal markers Next-Week ExpectancyNegative 43.30%Next-week expectancy is negative with a 43.30% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment41/100Weighted news tone is negative across 13 relevant articles.
Equities Analysts Issue Forecasts for AVTX Q3 Earnings Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 7.06 EUR | 7.6% | 7.22 EUR | 16.97 EUR | -0.72 | -15.98 | 586.5K | Off |
| 31 Jul 2026 | 6.56 EUR | 0.8% | 7.22 EUR | 17.11 EUR | -0.67 | -22.98 | 508.5K | Off |
| 24 Jul 2026 | 6.51 EUR | -6.7% | 7.23 EUR | 17.26 EUR | -0.48 | -24.74 | 461.3K | Off |
| 17 Jul 2026 | 6.98 EUR | -1.6% | 7.24 EUR | 17.40 EUR | -0.17 | -21.32 | 391.6K | On |
| 10 Jul 2026 | 7.09 EUR | -3.8% | 7.22 EUR | 17.55 EUR | 0.18 | -21.39 | 537.4K | On |
| 3 Jul 2026 | 7.37 EUR | -3.4% | 7.20 EUR | 17.69 EUR | 0.46 | -20.00 | 38.3K | On |
| 26 Jun 2026 | 7.63 EUR | -5.9% | 7.19 EUR | 17.83 EUR | 0.75 | -17.24 | 64.6K | On |
| 19 Jun 2026 | 8.11 EUR | 4.0% | 7.18 EUR | 17.98 EUR | 1.01 | -14.71 | 154.3K | On |
| 12 Jun 2026 | 7.80 EUR | -11.6% | 7.11 EUR | 18.12 EUR | 1.20 | -19.43 | 309.8K | On |
| 5 Jun 2026 | 8.82 EUR | 1.6% | 7.06 EUR | 18.27 EUR | 1.36 | -6.81 | 231.8K | On |
| 29 May 2026 | 8.68 EUR | -6.0% | 6.97 EUR | 18.41 EUR | 1.51 | -9.09 | 1.4M | On |
| 22 May 2026 | 9.23 EUR | 13.1% | 6.89 EUR | 18.56 EUR | 1.46 | -6.39 | 1.7M | On |
| 15 May 2026 | 8.16 EUR | 0.4% | 6.80 EUR | 18.69 EUR | 1.37 | -15.25 | 1.0M | On |
| 8 May 2026 | 8.13 EUR | 9.4% | 6.75 EUR | 18.82 EUR | 1.42 | -16.77 | 3.4M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.